EN
抗体药类似物
Research Grade Alefacept
All
TD-HY113036_1
  • CatalogTD-HY113036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsCD58-Fc,LFA3-Fc,CAS:222535-22-0
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Alefacept


Catalog No. TD-HY113036
Species reactivity Human
Applications Research Grade Biosimilar
Isotype Fusion - [CD58 (LFA3, lymphocyte function associated antigen 3)]2 - IGHG1 Fc (Fragment constant)
Expression system Mammalian Cells
Target Erythrocyte receptor, SRBC, T-cell surface antigen CD2, Rosette receptor, CD2, LFA-3 receptor, T-cell surface antigen T11/Leu-5, LFA-2
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P06729
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names CD58-Fc,LFA3-Fc,CAS:222535-22-0
Background Alefacept (BG 9273) is a human lymphocyte function-associated antigen 3/immunoglobulin 1 fusion protein. Alefacept can be used for the research of chronic plaque psoriasis.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY113036_1.jpg
Bioactivity
 
Detects CD2 in indirect ELISAs.